Literature DB >> 32413838

Overlapping demyelinating syndrome (Neuromyelitis optica spectrum disorders NMOSD with anti-NMDA receptor encephalitis); A case report.

Ahmed Al Sinani1, Said Al Maawali2, Jalila Alshekaili3, Mahmood Al Kindi3, Khalsa Al Ramadhani4, Jaber Al Khabouri5, Ahmed Nadeem5, Abdullah Al Salti6.   

Abstract

Neuromyelitis optica spectrum disorder (NMOSD) represents an evolving spectrum of inflammatory demyelinating central nervous system-based autoimmune diseases; while anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is another severe immune-mediated syndrome that occurs in association with IgG antibodies against the GluN1 subunit of the NMDAR and has been predominantly reported in young females (Dalmau et al., 2008 Dec). Although It has been recognized that anti-NMDAR encephalitis can coexist in the same patient who has serological markers of another autoimmune disease (e.g. neuronal autoantibodies and demyelination AQP4 or MOG antibodies) (Titulaer et al., 2014), rare cases are reported with anti-NMDAR encephalitis that overlap with a demyelinating syndrome; such as neuromyelitis optica spectrum disorders associated with Anti- Aquaporin 4 (AQP4) antibodies (Titulaer et al., 2013). We report here an unusual and rare overlapping autoimmune syndrome in a young Omani female who first presented in 2011 with the clinical and radiological presentations of neuromyelitis optica spectrum disorder (NMOSD) and had a complete recovery. Five years later, she was admitted with the diagnosis of anti-NMDAR encephalitis and was found to have positive serum as well as CSF analyses results for AQP4 and anti-NMDAR antibodies. The patient showed significant improvement, for both clinical syndromes with good response to steroid and immunomodulating therapy.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-N-methyl-D-aspartate receptor (anti-NMDAR); Encephalitis; Intravenous immunoglobulin IVIG; Neuromyelitis optica spectrum disorders (NMOSD); Rituximab; overlap demyelinating syndrome

Year:  2020        PMID: 32413838     DOI: 10.1016/j.msard.2020.102153

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  5 in total

Review 1.  Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review.

Authors:  Shujiang Zhang; Yuan Yang; Wenyu Liu; Zuoxiao Li; Jinmei Li; Dong Zhou
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

2.  Chronic Cognitive Impairment in AQP4+ NMOSD With Improvement in Cognition on Eculizumab: A Report of Two Cases.

Authors:  Georges Saab; David G Munoz; Dalia L Rotstein
Journal:  Front Neurol       Date:  2022-05-13       Impact factor: 4.086

3.  Overlapping anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis with neuromyelitis optica spectrum disorders: a case report.

Authors:  Jialin Pan; Begench Ovlyakulov; Lili Zhou
Journal:  Eur J Med Res       Date:  2022-05-09       Impact factor: 4.981

4.  Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report.

Authors:  Pei Liu; Miao Bai; Xu Yan; Kaixi Ren; Jiaqi Ding; Daidi Zhao; Hongzeng Li; Yaping Yan; Jun Guo
Journal:  Ther Adv Neurol Disord       Date:  2020-10-29       Impact factor: 6.570

5.  Myelin Oligodendrocyte Glycoprotein Antibody Associated Cerebral Cortical Encephalitis: Case Reports and Review of Literature.

Authors:  Hang Shu; Manqiu Ding; Pei Shang; Jia Song; Yue Lang; Li Cui
Journal:  Front Hum Neurosci       Date:  2022-01-03       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.